From Discovery To Delivery: Addressing Challenges in Cell Therapy

Biotech’s Brave New World: Bay Area startups band together to ramp up coronavirus research and testing

JP Morgan Healthcare Conference 2021, Day Two:Qiagen, Invitae, Agilent, Sema4, More

Finding the Best Cell for the Job

Pinpointing Bioprocess Development Success

Big Tech Is Under Pressure. Here’s Where to Find Growth

Berkeley Lights Helps Researchers Connect Genomic, Functional Characteristics of Cells

Soaring Biomedical IPOs Raise Questions About Money Left on the Table

Berkeley Lights Will Receive IPO of the Year Award at SynBioBeta 2020

Optofluidics Technology Accelerates Discovery of COVID-19 Treatments

Q&A: Distributed Biological Processing Can Prevent Pandemics

Bioeconomy Powerhouse Berkeley Lights Nearly Triples Since IPO, Now Valued At $3.9 Billion

Health Care CEO Does 180 Zoom Calls In Three Days to Help Take Company Public

A Singular View of COVID-19

Samsung Biologics Launches S-CHOice Cell Line Expression Technology

Light-Based Chips Speed up Cell-Line Development for GSK

Berkeley Lights flies high with $178M IPO

Berkeley Lights, Inc. Rings the Opening Bell in Celebration of its IPO

1
2
3